British Journal of Cancer

FIGURE 1

FROM:

Tissue and plasma expression of the angiogenic peptide adrenomedullin in breast cancer

M K Oehler, D C Fischer, M Orlowska-Volk, F Herrle, D G Kieback, M C P Rees and R Bicknell

BACK TO ARTICLE

Figure 1.

Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

Characterisation of the anti-ADM monoclonal antibody 171. (A) Solid-phase ELISA using antibody 171 against ADM (circle), amylin (square) and CGRP (triangle). (B) Immunoblotting of supernatant from transfected ADM-overexpressing RL95.2 cell clones and synthetic ADM. (C) Immunostaining of ADM-overexpressing RL95.2 cell clones and controls. (Brown indicates immunostaining.)

BACK TO ARTICLE